Peptide Sherpa

What Is Semaglutide?

Semaglutide is a GLP-1 receptor agonist — a drug that mimics glucagon-like peptide-1, a hormone your gut naturally releases after you eat. GLP-1 plays a key role in regulating blood sugar and appetite. Semaglutide was originally developed to treat type 2 diabetes, but researchers quickly noticed that patients on it lost significant weight. That discovery led to FDA approval for chronic weight management in 2021.

How Does Semaglutide Cause Weight Loss?

Semaglutide works through several mechanisms at once:

Appetite suppression. Semaglutide acts on receptors in the brain — specifically the hypothalamus — to reduce hunger signals. Most patients report feeling full much faster and simply not thinking about food as much as they used to.

Slowed gastric emptying. Semaglutide slows the rate at which food leaves your stomach. This keeps you feeling full longer after meals, reducing the urge to snack between them.

Blood sugar regulation. By stimulating insulin release in response to meals and suppressing glucagon, semaglutide helps keep blood sugar stable — reducing the energy crashes that often trigger cravings.

What Results Can You Expect?

Clinical trials have shown impressive results. The STEP 1 trial — the landmark study for Wegovy — found that participants lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% for placebo. That translates to roughly 33 pounds for someone starting at 220 pounds.

Results vary based on starting weight, dose, diet, and activity level. Most people begin to notice reduced appetite within the first few weeks. Meaningful weight loss typically becomes visible around weeks 8–12.

Who Is a Good Candidate for Semaglutide?

Semaglutide for weight loss is FDA-approved for adults who have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. It’s meant to be used alongside diet and exercise, not as a substitute for them.

It’s not appropriate for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. A telehealth provider can walk you through whether it’s right for you based on your health history.

What Are the Side Effects?

The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These are most pronounced when starting the medication or increasing the dose, and tend to improve after the first few weeks as your body adjusts. Taking semaglutide with a small meal and staying hydrated can help.

More serious side effects are rare but worth knowing about: pancreatitis, gallbladder disease, and kidney problems have been reported. Again, a licensed provider can help you weigh the benefits against your individual risk profile.

How Is It Administered?

Semaglutide for weight loss is given as a once-weekly subcutaneous injection — a small needle injected into the fat just under the skin of the abdomen, thigh, or upper arm. The dosing starts low and is gradually increased over several months to minimize side effects and allow the body to adapt.

Compounded semaglutide — available through licensed telehealth providers and partner pharmacies — can offer a more affordable alternative to brand-name Wegovy, which can cost over $1,000/month without insurance.

The Bottom Line

Semaglutide is one of the most effective weight loss tools available today. It works by reducing hunger, slowing digestion, and stabilizing blood sugar — making it significantly easier to eat less without feeling deprived. For many people, it’s been genuinely life-changing.

If you’re considering GLP-1 therapy, BreezeMeds offers online consultations with licensed providers and ships compounded semaglutide directly to your door — starting at $199/month. Learn more at breezemeds.com.